Brief: CVS Expects FY Adj EPS $7.90 To $8.10 VS IBES Estimate $7.45
BRIEF-CVS Expects FY Adj EPS $7.90 To $8.10 VS IBES Estimate $7.45 Aug 5 (Reuters) - CVS Health Corporation CVS.N:
CVS Q2 ADJUSTED EPS $2.58 VERSUS. IBES ESTIMATE $1.85
CVS OUTLOOK FY ADJUSTED EPS $7.90 TO $8.10 VERSUS. IBES ESTIMATE $7.45
CVS Q2 REVENUE $106.10 BILLION VERSUS. IBES ESTIMATE $100.11 BILLION
CVS: MAINTAINING CAUTIOUS VIEW FOR REMAINDER OF YEAR IN LIGHT OF CONTINUED ELEVATED COST TRENDS, POTENTIAL FOR MACRO HEADWINDS
CVS: BY EARLY Q4, ZEPBOUND & FOUNDAYO PATIENTS TO BE ABLE TO VIEW TRANSPARENT PRICING, INCLUDING CASH-PAY OPTIONS
CVS OUTLOOK FY CASH FLOW FROM OPERATIONS TO AT LEAST $11.5 BILLION
CVS: TO OFFER $29 MINUTECLINIC VIRTUAL VISITS FOR PATIENTS SEEKING GLP-1 MEDICATIONS
CVS Q2 MEDICAL BENEFIT RATIO AT 87.4% VERSUS IBES ESTIMATE 90.03%
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CVS Health
See all newsHealth Rounds: GLP-1 drugs tied to heart improvements in patients with obesity and heart failure
US health insurers fall for third day on CMS audit proposal, Medicare-for-All concerns
Health insurers extend decline on proposed new rule to curb fraud
Health insurers extend decline on proposed new rule to curb fraud
UnitedHealthcare to expand program paying pharmacists for medical services